A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

Clinical trial NCT05687071 · COMPLETED

Trial details

NCT number: NCT05687071
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyper-low-density Lipoprotein (LDL) Cholesterolemia

Start date: 2023-02-27
Primary completion: 2024-10-05
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.